Table: begin end state 1 22 cytoplasmic 23 40 transmembrane 41 42 non-cytoplasmic 43 66 transmembrane 67 101 cytoplasmic 102 124 transmembrane 125 129 non-cytoplasmic 130 151 transmembrane 152 159 cytoplasmic 160 183 transmembrane 184 204 non-cytoplasmic 205 227 transmembrane 228 247 cytoplasmic 248 269 transmembrane 270 280 non-cytoplasmic 281 304 transmembrane 305 339 cytoplasmic 340 360 transmembrane 361 365 non-cytoplasmic 366 392 transmembrane 393 411 cytoplasmic 412 430 transmembrane 431 435 non-cytoplasmic 436 454 transmembrane 455 473 cytoplasmic
Input: >Pf1N1B4_4976 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4976 MKSDTHEITEQAVLQRTLSNRHIQLMAMGGAIGTGLFMGSGKIIALSGTSIILIYMIIGL FVYFVMRAMGELLLSNLNFKSFADFAGAYLGPRAAFFLGWSYWLSWSVAVVGDAVVVGGF FQYWFPDVPAWIPAIGMMLTLFALNVLTVKLFGEVEFWFAIIKIIAVVALISVSVLLIAS SFVSPTGVTASLTHLLDKQAAFPNGLFGFFAGFQMAIFSFAGTELIGTAAAETRSPEKTL PKAINSIPLRIILFYVLSLVCIIAVTSWQQVSPNKSPFVELFLIAGFPAAAGIVNFVVLT SAASSANSGVFSSSRMLFGLADLGNAPGIFRRLSKNSVPLISLAFTTFLMLLGVLLLFII PEVMTAFTIVSTVSAILVIFTWSTILASYIAYRKARPDLHAQSRYKMPGGVPMAWFSLAF LAFVLCLLALRPDTRLALCVMPAWFIWLAIAYQFSHFKSRNQASHAAGSLLKE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server